Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
UNKNOWN
NCT05544032
Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD)
Sponsor: Incyte Corporation
View on ClinicalTrials.gov
Summary
This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee and Single Patient IND approval.
Key Details
Gender
Not specified
Age Range
Any - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-07-10
Healthy Volunteers
Not specified
Conditions
Interventions
DRUG
axatilimab
Treatment with axatilimab includes receiving intravenous (IV) doses of axatilimab every 2 weeks